Table 1.

Participant demographics and cancer-specific characteristics at baseline.

Full sampleNo cancerCancer
(N = 233,135)(n = 202,732)(n = 30,403)
M (SD) or %M (SD) or %M (SD) or %
Age (years)61.82 (5.36)61.61 (5.39)63.22 (5.00)
BMI26.93 (4.91)26.91 (4.94)27.02 (4.74)
White92.41%92.23%93.60%
Male56.69%55.13%67.08%
Self-reported health status
 Excellent18.98%19.29%16.96%
 Very good37.46%37.52%37.10%
 Good33.20%32.93%35.00%
 Fair8.19%8.11%8.69%
 Poor0.87%0.87%0.87%
Frailty index
 Robust58.31%58.83%54.85%
 Prefrail32.35%32.00%34.65%
 Mildly frail7.74%7.60%8.71%
 Moderately to severely frail1.19%1.17%1.27%
Cancer stage
 011.06%
 I67.43%
 II7.51%
 III5.14%
 Unknown8.86%
Cancer treatment
 Chemotherapy10.41%
 Radiation27.20%
 Surgery59.29%
Time between diagnosis and ambulatory function assessment (y)4.55 (2.83)
  • Abbreviations: BMI, body mass index; M, mean; SD, standard deviation.